JP Stock MarketDetailed Quotes

Sumitomo Pharma (4506)

Watchlist
  • 1729.5
  • +10.0+0.58%
20min DelayMarket Closed May 1 15:30 JST
776.90BMarket Cap29.07P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sumitomo Pharma (4506) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
Total revenue
120.62B
19.11%108B
26.79%398.83B
19.80%90.68B
-43.38%314.56B
79.53B
-41.56%82.39B
-51.73%76.96B
-52.66%75.69B
-0.80%555.54B
Cost of revenue
55.44B
26.22%44.11B
21.22%153.44B
14.85%34.95B
-29.25%126.58B
33.39B
-29.96%32.87B
-36.11%29.89B
-33.93%30.43B
13.87%178.92B
Gross profit
65.19B
14.65%63.89B
30.54%245.4B
23.14%55.73B
-50.09%187.98B
46.14B
-47.35%49.52B
-58.21%47.06B
-60.24%45.26B
-6.52%376.63B
Operating expense
52.19B
-27.16%42.85B
-60.27%215.69B
-39.24%58.83B
19.67%542.82B
283.23B
-2.59%80.77B
-47.49%81.99B
-2.40%96.82B
32.37%453.6B
Selling and administrative expenses
--42.94B
-21.39%35.66B
-57.95%180.61B
-39.43%45.36B
15.06%429.54B
--237.98B
-29.48%57.51B
-54.72%59.15B
-3.10%74.89B
49.88%373.32B
-General and administrative expense
--42.94B
-21.39%35.66B
-57.95%180.61B
-39.43%45.36B
15.06%429.54B
--237.98B
-29.48%57.51B
-54.72%59.15B
-3.10%74.89B
49.88%373.32B
Research and development costs
--10.35B
-37.71%8.18B
-55.73%49.87B
-52.87%13.12B
-14.58%112.64B
--38.99B
-10.47%23.29B
-11.92%22.51B
14.01%27.84B
38.94%131.86B
Other operating expenses
--345M
-42.90%366M
-56.07%3.57B
51.54%641M
382.33%8.13B
--6.61B
51.72%663M
20.27%439M
49.47%423M
53.83%1.69B
Total other operating income
--1.44B
360.96%1.35B
145.07%18.36B
-95.39%292M
-85.94%7.49B
--343M
-97.20%702M
-71.79%110M
127.22%6.34B
2,113.47%53.26B
Operating profit
13B
777.55%21.04B
108.37%29.71B
93.98%-3.11B
-360.95%-354.84B
-237.09B
-380.54%-31.25B
19.75%-34.93B
-452.86%-51.57B
-227.80%-76.98B
Net non-operating interest income (expenses)
-4.88B
-141.70%-8.47B
-135.26%-11.19B
-1.01%20.31B
9.24%31.75B
19.19B
40.57%-17.82B
-45.10%9.86B
-35.88%20.52B
27.86%29.06B
Non-operating interest income
--258M
-97.38%585M
-93.60%2.31B
4.78%22.33B
11.81%36.02B
--20.73B
----
-43.11%10.71B
-35.17%21.32B
24.99%32.22B
Non-operating interest expense
--5.14B
347.06%9.05B
215.64%13.5B
153.13%2.03B
35.39%4.28B
--1.54B
-40.57%17.82B
-1.73%851M
-9.40%800M
3.57%3.16B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
620M
-638M
-3,834.78%-905M
-23M
Special income (charges)
Other non-operating income (expenses)
Income before tax
8.74B
-30.64%11.93B
105.45%17.61B
155.40%17.2B
-574.28%-323.11B
-217.92B
-160.40%-49.06B
1.96%-25.08B
-166.62%-31.05B
-157.76%-47.92B
Income tax
-80M
-42.70%726M
26.40%-6.02B
-83.78%1.27B
-116.77%-8.19B
-20.69B
161.66%899M
-78.61%3.8B
-57.83%7.81B
15.19%48.79B
Net income
8.82B
-29.68%11.21B
107.50%23.64B
141.01%15.94B
-225.63%-314.93B
-197.23B
-187.41%-49.96B
33.37%-28.87B
-238.34%-38.86B
-338.21%-96.71B
Net income continuous operations
--8.82B
-29.68%11.21B
107.50%23.64B
141.01%15.94B
-225.63%-314.93B
---197.23B
-187.41%-49.96B
33.37%-28.87B
-238.34%-38.86B
-338.21%-96.71B
Noncontrolling interests
0
0
-97.50%1M
66.67%-1M
100.18%40M
31M
100.06%4M
100.04%2M
99.90%-3M
-40.40%-22.2B
Net income attributable to the company
8.82B
-29.69%11.21B
107.50%23.63B
141.01%15.94B
-322.71%-314.97B
-197.26B
-345.38%-49.97B
24.78%-28.88B
-224.92%-38.86B
-232.08%-74.51B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
6M
0
Net income attributable to common stockholders
8.82B
-29.69%11.21B
107.50%23.63B
141.01%15.94B
-322.71%-314.97B
-197.26B
-345.38%-49.97B
24.78%-28.88B
-224.94%-38.87B
-232.08%-74.51B
Gross dividend payment
Basic earnings per share
22.19
-29.67%28.21
107.50%59.49
141.00%40.11
-322.71%-792.79
-496.51
-345.36%-125.77
24.79%-72.68
-224.93%-97.82
-232.09%-187.55
Diluted earnings per share
22.19
-29.67%28.21
107.50%59.49
141.00%40.11
-322.71%-792.79
-496.5154
-345.36%-125.77
24.79%-72.68
-224.93%-97.82
-232.09%-187.55
Dividend per share
0
0
0
0
0
0
0
0
0
-25.00%21
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023
Total revenue 120.62B19.11%108B26.79%398.83B19.80%90.68B-43.38%314.56B79.53B-41.56%82.39B-51.73%76.96B-52.66%75.69B-0.80%555.54B
Cost of revenue 55.44B26.22%44.11B21.22%153.44B14.85%34.95B-29.25%126.58B33.39B-29.96%32.87B-36.11%29.89B-33.93%30.43B13.87%178.92B
Gross profit 65.19B14.65%63.89B30.54%245.4B23.14%55.73B-50.09%187.98B46.14B-47.35%49.52B-58.21%47.06B-60.24%45.26B-6.52%376.63B
Operating expense 52.19B-27.16%42.85B-60.27%215.69B-39.24%58.83B19.67%542.82B283.23B-2.59%80.77B-47.49%81.99B-2.40%96.82B32.37%453.6B
Selling and administrative expenses --42.94B-21.39%35.66B-57.95%180.61B-39.43%45.36B15.06%429.54B--237.98B-29.48%57.51B-54.72%59.15B-3.10%74.89B49.88%373.32B
-General and administrative expense --42.94B-21.39%35.66B-57.95%180.61B-39.43%45.36B15.06%429.54B--237.98B-29.48%57.51B-54.72%59.15B-3.10%74.89B49.88%373.32B
Research and development costs --10.35B-37.71%8.18B-55.73%49.87B-52.87%13.12B-14.58%112.64B--38.99B-10.47%23.29B-11.92%22.51B14.01%27.84B38.94%131.86B
Other operating expenses --345M-42.90%366M-56.07%3.57B51.54%641M382.33%8.13B--6.61B51.72%663M20.27%439M49.47%423M53.83%1.69B
Total other operating income --1.44B360.96%1.35B145.07%18.36B-95.39%292M-85.94%7.49B--343M-97.20%702M-71.79%110M127.22%6.34B2,113.47%53.26B
Operating profit 13B777.55%21.04B108.37%29.71B93.98%-3.11B-360.95%-354.84B-237.09B-380.54%-31.25B19.75%-34.93B-452.86%-51.57B-227.80%-76.98B
Net non-operating interest income (expenses) -4.88B-141.70%-8.47B-135.26%-11.19B-1.01%20.31B9.24%31.75B19.19B40.57%-17.82B-45.10%9.86B-35.88%20.52B27.86%29.06B
Non-operating interest income --258M-97.38%585M-93.60%2.31B4.78%22.33B11.81%36.02B--20.73B-----43.11%10.71B-35.17%21.32B24.99%32.22B
Non-operating interest expense --5.14B347.06%9.05B215.64%13.5B153.13%2.03B35.39%4.28B--1.54B-40.57%17.82B-1.73%851M-9.40%800M3.57%3.16B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests 620M-638M-3,834.78%-905M-23M
Special income (charges)
Other non-operating income (expenses)
Income before tax 8.74B-30.64%11.93B105.45%17.61B155.40%17.2B-574.28%-323.11B-217.92B-160.40%-49.06B1.96%-25.08B-166.62%-31.05B-157.76%-47.92B
Income tax -80M-42.70%726M26.40%-6.02B-83.78%1.27B-116.77%-8.19B-20.69B161.66%899M-78.61%3.8B-57.83%7.81B15.19%48.79B
Net income 8.82B-29.68%11.21B107.50%23.64B141.01%15.94B-225.63%-314.93B-197.23B-187.41%-49.96B33.37%-28.87B-238.34%-38.86B-338.21%-96.71B
Net income continuous operations --8.82B-29.68%11.21B107.50%23.64B141.01%15.94B-225.63%-314.93B---197.23B-187.41%-49.96B33.37%-28.87B-238.34%-38.86B-338.21%-96.71B
Noncontrolling interests 00-97.50%1M66.67%-1M100.18%40M31M100.06%4M100.04%2M99.90%-3M-40.40%-22.2B
Net income attributable to the company 8.82B-29.69%11.21B107.50%23.63B141.01%15.94B-322.71%-314.97B-197.26B-345.38%-49.97B24.78%-28.88B-224.92%-38.86B-232.08%-74.51B
Preferred stock dividends
Other under preferred stock dividend 000000006M0
Net income attributable to common stockholders 8.82B-29.69%11.21B107.50%23.63B141.01%15.94B-322.71%-314.97B-197.26B-345.38%-49.97B24.78%-28.88B-224.94%-38.87B-232.08%-74.51B
Gross dividend payment
Basic earnings per share 22.19-29.67%28.21107.50%59.49141.00%40.11-322.71%-792.79-496.51-345.36%-125.7724.79%-72.68-224.93%-97.82-232.09%-187.55
Diluted earnings per share 22.19-29.67%28.21107.50%59.49141.00%40.11-322.71%-792.79-496.5154-345.36%-125.7724.79%-72.68-224.93%-97.82-232.09%-187.55
Dividend per share 000000000-25.00%21
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -